Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S8.73
P/E—
Fwd P/E30.15
PEG2.82
52W— – —
RSI—
Target$698.92 (+38.5%)
Beta1.54
Div—
Loading chart…
RSI ()
Loading patterns…
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 31
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
5Bearish
0Neutral
Key Signals 2
▲ Inv. Head & Shoulders
Major reversal
2026-08-04 · $579.31
Inv. H&S neckline ~$579.31 broken — major bullish reversal
Learn more →
▲ Double Bottom
Major reversal
2026-08-04 · $577.15
Two lows ~$527.35 — bullish reversal confirmed
Learn more →
Momentum Signals 9
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ Bull Flag
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$698.92
+38.5% upside
Low $470
—
High $805
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
62.45%Last 12 Months
Operating Margin
34.98%Last 12 Months
Return on Equity
74.21%Last 12 Months
Revenue Growth
9.70%Year over Year
Free Cash Flow
909.37MLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
67.97Most Recent Quarter
Current Ratio
1.17Most Recent Quarter
Cash
196.93MMost Recent Quarter
Total Debt
1.10BMost Recent Quarter
Net Debt
—Most Recent Quarter
How IDXX Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 39.76B |
| Enterprise Value | 40.66B |
| Trailing P/E | 35.59 |
| Forward P/E | 30.15 |
| PEG Ratio (5yr) | 2.82 |
| Price/Sales (ttm) | 8.73 |
| Price/Book (mrq) | 24.69 |
| EV/Revenue | 8.93 |
| EV/EBITDA | 25.07 |
Share Statistics
| Avg Vol (3m) | 621.22K |
| Shares Outstanding | 78.78M |
| Float | 78.50M |
| % Held by Insiders | 0.22% |
| % Held by Institutions | 96.74% |
| Short Ratio | 3.41 |
| Short % of Float | 3.04% |
Profitability
| Gross Margin | 62.45% |
| Operating Margin (ttm) | 34.98% |
| Profit Margin | 25.03% |
| Return on Assets (ttm) | 27.08% |
| Return on Equity (ttm) | 74.21% |
Income Statement
| Revenue (ttm) | 4.55B |
| Revenue Growth (yoy) | 9.70% |
| Gross Profit (ttm) | 2.84B |
| EBITDA | 1.62B |
| Net Income (ttm) | 1.14B |
| Diluted EPS (ttm) | 14.18 |
| EPS Growth (yoy) | 17.60% |
Balance Sheet
| Total Cash (mrq) | 196.93M |
| Total Debt (mrq) | 1.10B |
| Debt / Equity (mrq) | 67.97 |
| Current Ratio (mrq) | 1.17 |
| Book Value / Share | 20.45 |
| Operating CF (ttm) | 1.37B |
| Free Cash Flow (ttm) | 909.37M |
Trading & Dividends
| Beta (5Y) | 1.54 |
| 50-Day MA | 556.71 |
| 200-Day MA | 604.57 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
No dividend history available for IDXX.
Ownership Breakdown
Institutional 96.74%
Insider 0.22%
Public 3.0%
Short Interest
3.04% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in IDXX in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|